We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Novel Magnetic Resonance System Rapidly Determines Malaria Parasite Load

By LabMedica International staff writers
Posted on 07 Sep 2014
A novel diagnostic technique based on magnetic resonance relaxometry (MRR) was able to rapidly and accurately determine severity of malaria infection without using chemical or immunolabeling.

When malaria parasites grow within host red blood cells they metabolize large amounts of hemoglobin and convert it into hemozoin crystallites. More...
These hemozoin particles possess relatively large paramagnetic susceptibility, which induces substantial changes in the transverse relaxation rate of proton nuclear magnetic resonance of infected red blood cells. The relaxation rate is a measure of how the nuclear magnetic resonance of hydrogen atoms is affected by the proximity of other magnetic particles – in this case hemozoin.

Researchers at the Massachusetts Institute of Technology (Cambridge, USA) and colleagues at Nanyang Technical University (Singapore) prepared a benchtop size MRI instrument around a 0.5-Tesla magnet, which was less expensive and powerful than the 2- or 3-Tesla magnets typically required for MRI diagnostic imaging. They used this instrument to determine numbers of Plasmodium falicparum parasites growing in vitro and Plasmodium berghei parasites taken from infected mice. Blood samples of 10 microliters or less were concentrated by centrifugation and then analyzed without further preparation or labeling.

Results revealed that a parasitemia level of fewer than ten parasites per microliter in a volume below 10 microliters of whole blood was detected in a few minutes for cultured Plasmodium falciparum parasites and in vivo with Plasmodium berghei-infected mice.

"Hemozoin crystals are produced in all four stages of malaria infection, including the earliest stages, and are generated by all known species of the Plasmodium parasite," said senior author Dr. Jongyoon Han, professor of electrical engineering and biological engineering at the Massachusetts Institute of Technology. "Also, the amount of hemozoin can reveal how severe the infection is, or whether it is responding to treatment. There are a lot of scenarios where you want to see the number, rather than a yes or no answer. There is real potential to make this into a field-deployable system, especially since you do not need any kind of labels or dye. It is based on a naturally occurring biomarker that does not require any biochemical processing of samples."

A paper describing the technique was published in the August 31, 2014, online edition of the journal Nature Medicine.

Related Links:

Massachusetts Institute of Technology
Nanyang Technical University



Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Amoebiasis Test
ELI.H.A Amoeba
New
PSA Test
Humasis PSA Card
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.